
BLU2864 is an orally active, highly селективный, ATP-competitive PRKACA ингибитор (IC50=0.3 nM). BLU2864 shows anti-tumor activity. BLU2864 can be used in cancer and polycystic kidney disease research.
BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor (IC50=0.3 nM). BLU2864 shows anti-tumor activity. BLU2864 can be used in cancer and polycystic kidney disease research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.